Umbria Bioengineering Technologies
PrivateLast Round
Grant
Nov 28, 2022
Total Funding Raised
$3.97M
Company Overview
Umbria Bioengineering Technologies operates in Healthcare & Life Sciences and is based in Assisi. Its latest recorded funding round was a Grant round in November 2022.
Umbria Bioengineering Technologies is a biomedical company that develops and commercializes innovative medical imaging devices based on microwave technology as a safe, non-ionizing alternative to X-rays.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Umbria Bioengineering Technologies Comparables
Compare Umbria Bioengineering Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MIMA Technologies P.C. | 89% | |
| Micrima Ltd. | 85% | |
| Microwave Vision Group | 83% |
For institutional investors. Book with your work email.
Umbria Bioengineering Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 28, 2022 | ||||
| Grant | Oct 1, 2018 | ||||
| Grant | Aug 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Umbria Bioengineering Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UKRI Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Monthly visitors increased 107% MoM.
- Jan 20, 2026
Monthly visitors increased 38% MoM.
For institutional investors. Book with your work email.
Umbria Bioengineering Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Umbria Bioengineering Technologies's valuation, stock price, and market status.
Is Umbria Bioengineering Technologies a public or private company?
Umbria Bioengineering Technologies is a private company.
What is the current stock price of Umbria Bioengineering Technologies?
Umbria Bioengineering Technologies is a private company, so its shares have no public market price. Caplight tracks Umbria Bioengineering Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Umbria Bioengineering Technologies worth (valuation)?
Valuation information for Umbria Bioengineering Technologies is not publicly available.
Can I buy Umbria Bioengineering Technologies stock?
Umbria Bioengineering Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Umbria Bioengineering Technologies's last funding round?
Umbria Bioengineering Technologies's most recent funding round was Grant on November 28, 2022.
Who are the main investors in Umbria Bioengineering Technologies?
Key investors in Umbria Bioengineering Technologies include UKRI Innovate UK.
Will Umbria Bioengineering Technologies IPO soon?
No public IPO plans have been announced for Umbria Bioengineering Technologies.
How can I track Umbria Bioengineering Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Umbria Bioengineering Technologies's shares on secondary markets.